Structural-based inhibitors of the glutathione binding site in aldose reductase …

Abstract

What is claimed is: 1. A method of treating lung cancer comprising administering a pharmacologically effective amount of an inhibitor of aldose reductase to a subject having lung cancer, wherein the aldose reductase inhibitor is fidarestat.